Advertisement
Advertisement

IMA

I

ImageneBio, Inc. Common Stock

7.52
USD
Sponsored
+0.20
+2.68%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

7.50

-0.02
-0.23%

IMA Earnings Reports

Positive Surprise Ratio

IMA beat 14 of 19 last estimates.

74%

Next Report

Date of Next Report
Mar 04, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.46
Implied change from Q3 25 (Revenue/ EPS)
--
/
-49.83%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-35.68%

ImageneBio, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, IMA reported earnings of -2.91 USD per share (EPS) for Q3 25, missing the estimate of -1.29 USD, resulting in a -125.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -1.46 USD, with revenue projected to reach -- USD, implying an decrease of -49.83% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, ImageneBio, Inc. Common Stock reported EPS of -$2.91, missing estimates by -125.09%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.7%, changed from $8.61 before the earnings release to $8.55 the day after.
The next earning report is scheduled for Mar 04, 2026.
Based on 4 analysts, ImageneBio, Inc. Common Stock is expected to report EPS of -$1.46 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement